Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure

Adrian daSilva-deAbreu1,2, Bader Aldeen Alhafez3, Carl J Lavie1,2

  • 1John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation.

Insights

Hypertension and obesity contribute to heart failure by causing cardiac remodeling. Managing weight and blood pressure can help reverse some damage and improve outcomes in heart failure patients.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Hypertension Research

Background:

  • Hypertension (HTN) and obesity are significant risk factors for cardiac remodeling and dysfunction.
  • These conditions can lead to left ventricular hypertrophy (LVH) and heart failure (HF).

Purpose of the Study:

  • To review the complex mechanisms linking HTN and obesity to cardiac remodeling and dysfunction.
  • To discuss the impact of treatments for HTN and obesity on LVH, ventricular function, and HF.

Main Methods:

  • Literature review of studies on hypertension, obesity, cardiac remodeling, and heart failure.
  • Analysis of neurohormonal, metabolic, and hemodynamic pathways involved.

Main Results:

  • Obesity and HTN affect the heart via shared neurohormonal pathways.
  • Additional metabolic and hemodynamic factors contribute to cardiac dysfunction in obesity.
  • Weight loss and blood pressure control mitigate cardiac damage beyond hemodynamic effects.

Conclusions:

  • Obesity and HTN induce maladaptive cardiac changes, promoting LVH and HF.
  • Interventions like weight loss and BP control can partially reverse these changes.
  • Improved clinical outcomes in HF patients are associated with weight and BP management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
153
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
646
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
71
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
68
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
187